Join the Schizoaffective Disorder group to help and get support from people like you.
Schizoaffective Disorder News (Page 2)
Blood Test to Predict Schizophrenia Shows Promise
TUESDAY, Feb. 13, 2024 — Researchers say they have developed a blood test for schizophrenia. More than 3 million people in the United States have schizophrenia, a disorder marked by hallucinations a...
Long-Acting Injectable Antipsychotics Cut Readmission for Schizophrenia
WEDNESDAY, Feb. 7, 2024 – For patients diagnosed with schizophrenia or schizoaffective disorder, long-acting injectable (LAI) antipsychotics show a significant reduction in 30-day readmission...
Patients Taking Psychiatric Meds Often Gain Weight. Scientists May Now Know Why
WEDNESDAY, Jan. 10, 2024 – Weight gain has long been an unwanted side effect of medicines commonly used to treat psychiatric conditions such as bipolar disorder or schizophrenia. Some patients may ...
ED Visits for Schizophrenia Spectrum Disorders Up After Pandemic Onset
WEDNESDAY, Dec. 27, 2023 – The number of emergency department visits for schizophrenia spectrum disorders increased after the onset of the COVID-19 pandemic, according to a study published online...
Brain Stimulation Can Improve Prospective Memory in Schizophrenia
WEDNESDAY, Dec. 6, 2023 – For patients with schizophrenia, bilateral high-frequency repetitive transcranial magnetic stimulation (rTMS) can improve event-based prospective memory (EBPM), according...
Racial Disparities Seen in Unmet Treatment Needs for Pediatric Mental Health
TUESDAY, Dec. 5, 2023 – For children with mental health conditions, there are racial and ethnic disparities in unmet treatment needs, according to a study published online Dec. 5 in Pediatrics....
Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHD
THURSDAY, Nov. 30, 2023 – The presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with...
Internet Poses No Threat to Mental Health, Major Study Finds
TUESDAY, Nov. 28, 2023 – It might seem that surfing the web could cause a person’s mental health to suffer, but a landmark new study has concluded that internet use poses no major threat to people’s ...
Neuromelanin-Sensitive MRI Linked to Psychosis Severity in Schizophrenia
MONDAY, Nov. 20, 2023 – Neuromelanin-sensitive magnetic resonance imaging (NM-MRI) contrast is associated with psychosis severity in antipsychotic-free patients with schizophrenia, according to a...
New Treatment Modality May Reduce Obesity in Schizophrenia Patients
FRIDAY, Nov. 17, 2023 – In individuals with schizophrenia, accelerated continuous theta burst stimulation (cTBS) seems promising for treating obesity, according to a study published online Oct. 31...
ED Visit for Substance Use With Psychosis Increases Risk for Schizophrenia Diagnosis
THURSDAY, Oct. 12, 2023 – Emergency department visits for substance use are associated with an increased risk for developing a schizophrenia spectrum disorder, according to a brief report published...
Polygenic Overlap Detected for Schizophrenia, CVD Risk
FRIDAY, Sept. 29, 2023 – For individuals with schizophrenia, there is a genetic propensity for smoking and a reduced risk for obesity, according to a study published online Sept. 27 in the American...
FDA Medwatch Alert: Paliperidone Extended-Release Tablets 3mg by Teva Pharmaceuticals: Recall - Dissolution Test Failure
ISSUE: Teva Pharmaceuticals USA, Inc. (Teva) initiated a voluntary recall to retail-level on 05/31/2017 for one lot of Paliperidone Extended-Release Tablets, 3mg, 90 count bottles, lot 1160682A,...
FDA Approves sNDA for Invega Sustenna (paliperidone palmitate) for Schizoaffective Disorder
TITUSVILLE, N.J., Nov. 13, 2014 /PRNewswire/ – Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Applications (sNDAs)...
Further information
Related condition support groups
Related drug support groups
Prozac, Seroquel, Abilify, fluoxetine, lithium, lamotrigine, quetiapine, olanzapine, risperidone, view more... aripiprazole, Risperdal, Seroquel XR, Geodon, Invega, Tegretol, Invega Sustenna